HEALEY PHARMA (UK) LIMITED
HEALEY PHARMA (UK) LIMITED
Add to Cart
FERROUS SULFATE + FOLIC ACID TABLETS
COMPOSITION:
Each tablet contains 200mg ferrous sulfate and 0.4mg folic acid.
PHARMACOLOGICAL ACTION:
Iron is an essential trace element that is required for the formation of haemoglobin and myoglobin important
components of the blood. Ferrous sulfate + Folic acid tablets also contain a sufficient amount of folic acid to
prevent the development of folate deficiency during pregnancy.
INDICATIONS:
Ferrous sulfate + Folic acid is indicated in pregnancy for the prevention and treatment of iron deficiency
anaemia and to supply a maintenance dosage of folic acid. It is also indicated for the general treatment of
iron deficiency of concomitant folic acid deficiency in non-pregnant patients.
CONTRA-INDICATIONS:
Ferrous sulfate + Folic acid is contra-indicated in patients with pernicious anaemia.
The use of Ferrous sulfate + Folic acid is contraindicated in the presence of intestinal diverticula or any
intestinal obstruction.
Iron preparations are contraindicated in patients with hemochromatosis and hemosiderosis.
Iron is contraindicated in patients receiving repeated blood transfusions.
Oral iron preparations are contraindicated when used concomitantly with parenteral iron therapy.
DOSAGE AND DIRECTIONS FOR USE:
The usual recommended dose for non-pregnant and pregnant adults is one tablet once a day, or as prescribed by the physician.
SIDE EFFECTS AND SPECIAL PRECAUTIONS:
Therapeutic doses of iron may cause gastro-intestinal discomfort, diarrhoea, and vomiting. These side-effects have been reported to occur in up to 20% or more of patients treated and are related to the amount
of elemental iron. Although iron is better absorbed between meals, side effects can be reduced by taking it with, or immediately after, food. Continued administration may sometimes cause constipation.
Large doses of ferrous sulphate may have irritant and corrosive effects on the gastro-intestinal mucosa and necrosis and perforation may occur: stricture formation may subsequently follow.
Symptoms, which may not appear for several hours, include epigastric pain, diarrhoea, vomiting and
haematemesis. Circulatory failure may follow if the diarrhoea and haemorrhage are severe. Hours or days
later, after apparent recovery, metabolic acidosis, convulsions, and coma may occur. If the patient survives,
symptoms of acute liver necrosis may develop and may lead to death due to hepatic coma.
STORAGE INSTRUCTIONS:
Store below 30°C in well closed container.
Keep out of reach of children.